Look for:

Our offer for

ABBOTT LABORATORIES


ISIN:
US0028241000
WKN:
002824100

2023/02/08 21:00:35
Price
110.249 USD
Difference -1.55% (-1.74)

General attributes

ISINUS0028241000
SymbolABT
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)181,995 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)110.23 USD (300)
Ask (Ask size)110.26 USD (200)
Open111.40 USD
High111.87 USD
Low110.08 USD
Close (prev. day)111.99 USD
VWAP110.636612 USD
Volume (pcs)2,395,201
Trading volume265,045,031.40
Number of trades29,059
Last size100

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ABBOTT LABORATORIESPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/02/08 21:00:35
Price
110.249 USD
Difference -1.55% (-1.74)

General attributes

ISINUS0028241000
SymbolABT
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)181,995 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)110.23 USD (300)
Ask (Ask size)110.26 USD (200)
Open111.40 USD
High111.87 USD
Low110.08 USD
Close (prev. day)111.99 USD
VWAP110.636612 USD
Volume (pcs)2,395,201
Trading volume265,045,031.40
Number of trades29,059
Last size100

Performance and Risk

6m1Y3Y
Perf (%)-2.74%-6.74%+30.14%
Perf (abs.)-2.94-7.55+24.18
Beta0.800.830.81
Volatility21.4724.4529.76
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)111.720 USD (4,177,170)
Ø price 30 days | Ø volume 30 days (pcs.)111.322 USD (4,632,809)
Ø price 100 days | Ø volume 100 days (pcs.)105.281 USD (5,488,185)
Ø price 250 days | Ø volume 250 days (pcs.)110.026 USD (5,289,437)
YTD High | date115.690 USD (2023/01/11)
YTD Low | date108.750 USD (2023/01/03)
52 Weeks High | date130.790 USD (2022/02/09)
52 Weeks Low | date93.250 USD (2022/10/21)

All listings for ABBOTT LABORATORIES

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/02/0817:35103.24 EUR0.0822
Vienna Stock Exchange2023/02/0817:32103.24 EUR0.002
Tradegate2023/02/0820:41102.72 EUR0.0617
Stuttgart2023/02/0808:07103.92 EUR0.001
SIX Swiss Exchange2023/01/1617:30103.00 CHF0.001
NYSE2023/02/0821:00110.249 USD265.0529,059
Munich2023/02/0818:20102.74 EUR0.012
London Stock Exchange2023/02/0813:03111.99 USD36.437
Hanover2023/02/0808:17103.96 EUR0.001
Hamburg2023/02/0810:16103.74 EUR0.062
Frankfurt2023/02/0813:49104.04 EUR0.013
Duesseldorf2023/02/0818:31102.42 EUR0.0011
Berlin2023/02/0820:31102.86 EUR0.0017
BX Swiss2023/02/0318:00102.692 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2546&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABBOTT LABORATORIES
- -
100 Abbott Park Road - 60064-6400 Abbott Park
Telefon: 1-224-667-6100
Fax: -
E-mail: -

PDF Downloads

Company report: ABBOTT LABORATORIESPDF Download

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.

Members of Management Board

Robert AlpernMember of Board of Directors
Sally BlountMember of Board of Directors
Claire Babineaux-FontenotMember of Board of Directors
Daniel StarksMember of Board of Directors
Darren McDewMember of Board of Directors
Glenn TiltonMember of Board of Directors
John StrattonMember of Board of Directors
Michael RomanMember of Board of Directors
Michelle KumbierMember of Board of Directors
Nancy McKinstryMember of Board of Directors
Paola GonzalezMember of Board of Directors
William OsbornMember of Board of Directors
Robert FordChairman of Managing Board
Gene HuangMember of Executive Committee
John CapekMember of Executive Committee
Andrea WainerMember of Executive Committee
Daniel Gesua Sive SalvadoriMember of Executive Committee
David MarkMember of Executive Committee
Hubert AllenMember of Executive Committee
Jim LeffelmanMember of Executive Committee
Karen ChayaviraboodMember of Executive Committee
Karen PetersonMember of Executive Committee
Kathryn CollinsMember of Executive Committee
Lisa EarnhardtMember of Executive Committee
Mary MorelandMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer